CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Journey II posterior cruciate retaining total knee arthroplasty +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03088748
NCT03088748N/ACompleted
CompareCT.gov

Kinematics in Posterior Cruciate Retaining and Bi-Cruciate Retaining Total Knee Replacements

The University of Tennessee, Knoxville·observational·Posted Mar 23, 2017·Updated Oct 12, 2021

In Brief

An observational study evaluating Journey II posterior cruciate retaining total knee arthroplasty and Journey II posterior bi-cruciate retaining total knee arthroplasty for Arthroplasty, Replacement, Knee and Osteoarthritis, Knee. Completed, enrolled 50 participants across 4 sites.

Detailed Summary

The purpose of the study is to acquire kinematic in vivo fluoroscopy data from subjects who were implanted with the Smith \& Nephew Journey II posterior cruciate retaining (PCR) total knee arthroplasty (TKA) or Journey II bi-cruciate retaining (BCR) TKA. CMR has previously collected data for the Smith \& Nephew BCS TKA and compared these kinematics data to those of normal knees.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasty, Replacement, Knee, Osteoarthritis, Knee
CountriesUnited States
CollaboratorsSmith & Nephew, Inc.

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 23, 2017
Enrollment StartJan 1, 2017
Primary CompletionNov 9, 2020
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 9.3 years ago

Interventions

Journey II posterior cruciate retaining total knee arthroplastydevice

Journey II posterior bi-cruciate retaining total knee arthroplastydevice